KB12NCT07941674
Persistent Vitamin B12 Hypervitaminemia: Identification of Biomarkers for the Early Detection of Solid Cancers
StatusNot Yet Recruiting
PhaseNot applicable
SponsorUniversity Hospital, Angers
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Between-group differences in vitamin B12-related biomarker concentrations
Timeframe: At inclusion (baseline blood sample)
Secondary (7)
Area under the receiver operating characteristic curve (AUC) for solid cancer detection
Cutoff values of vitamin B12-related biomarkers (Optimal diagnostic)
Sensitivity
specificity
positive predictive value of vitamin B12-related biomarkers
Show 2 moreShow less
negative predictive value of vitamin B12-related biomarkers
Association between vitamin B12-related biomarker concentrations and certain tumor characteristics
Arms and interventions
Persistent elevated B12Experimental
All participants with persistent hypercobalaminemia undergo the same study-specific blood sampling procedure for the measurement of vitamin B12-related biomarkers. Participants are classified into two predefined subgroups according to the underlying cause of hypercobalaminemia: solid cancer (CANCER group) or other identified causes (OTHER CAUSES group). No treatment or diagnostic procedure is assigned differently between the two subgroups.
Diagnostic tests: Blood-Based Vitamin B12 Biomarker Panel
Sites
3 sites in 1 country